I am constantly on the watch for biotech breakthroughs, new companies, and emerging opportunities in the biopharmaceutical industry. While my main focus is on various flavors of Artificial Intelligence (e.g. DL, GANs, NLP), I am also analyzing industry in such areas as quantum theory and computing, remote labs, automation and robotization, new digital tools and processes, novel therapeutic modalities — especially discovered using novel computational methods.